Viatris signals beyond the news: 48+ signals from 5 sources
The latest Viatris signal on this page is from Sep 29, 2026 (Patents): "Viatris Inc.'s patent output is steady: 1 grant in the past year, 0 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
Public (VTRS)Pharmaceutical Manufacturing10,000+ employeesviatris.comLinkedIn
- Signals
- 48+
- Sources
- 5
- Last 90 days
- 36
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Viatris signals by source
48+ signals for Viatris across 5 sources.
Patents · Patent pace
Viatris Inc.'s patent output is steady: 1 grant in the past year, 0 in the past 30 days.
Over the past year Viatris Inc. received 1 US patent grant; the recent pace (1 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 1
- Grants, 90 days
- 1
- Grants, 30 days
- 0
- USPTO assignee
- Viatris Inc.
Glassdoor · Reorg chaos
Tech Head describes frequent reorgs leading to instability
A former Tech Head from Shanghai reports frequent re-organizations and aggressive work environments, leading to personal instability within the company.
- Overall rating
- 3.8 of 5
- CEO approval
- 76%
- Reviews read
- 5
- Review window
- Aug 20, 2026 to Sep 2, 2026
Glassdoor · Compensation dissatisfaction
Marketing role receives multiple job titles with same pay and low WLB rating
A Marketing employee with 4 years of tenure received three job titles for one role without additional compensation, and reported a low work-life balance rating of 2.
- Overall rating
- 3.8 of 5
- CEO approval
- 76%
- Reviews read
- 5
- Review window
- Aug 20, 2026 to Sep 2, 2026
Glassdoor · Consistent leadership complaints
Employees report unresponsive management and restrictive hierarchical culture
Multiple reviews indicate that management is unresponsive to employee issues and email inquiries. One reviewer also notes a restrictive, hierarchical culture with significant top-down direction.
- Overall rating
- 3.8 of 5
- CEO approval
- 76%
- Reviews read
- 5
- Review window
- Aug 20, 2026 to Sep 2, 2026
Website changes · Funding news
Viatris added its second-quarter 2026 financial results to the homepage news feed.
Added: “Viatris Reports Second-Quarter 2026 Financial Results” with a link to the newsroom announcement dated 2026-08-06.
- Page
- /
Website changes · Marketing content
Viatris expanded its homepage’s featured content to emphasize patient impact, advocacy, and the company’s personal brand.
Added “Patient Inspiration Living With the Life-Altering Effects of Lupus,” “Voices of Viatris Two Little Words, and the Comeback of a Lifetime,” and “Access & Impact” under Stories of Ingenuity.
- Page
- /
Web traffic · Traffic snapshot
viatris.com received 107K monthly visits with traffic from 5 countries.
- Monthly visits
- 106,639
- Month over month
- +8.9%
- 3-month change
- -4.2%
- Global rank
- 368,313
LinkedIn
Enzy shares a customer story about resilience and support during a husband's health crisis.
Our colleague, Karla, navigated impossible decisions, advocated fiercely for her husband’s care and refused to accept anything less than hope. When her husband, Todd, couldn’t fight for himself after a massive heart attack and stroke, she fought for him. When the odds were overwhelming, she became the steady force...
- Likes
- 58
- Comments
- 0
- Tags
- Customer Experience, Health & Safety
- Initiatives
- sharing customer comeback story for inspiration
LinkedIn
Enzy shares a replay of their Q2 2026 financial results presentation.
In case you missed it, see a replay of our Q2 2026 financial results: https://lnkd.in/eP-wB3km
- Likes
- 134
- Comments
- 2
- Tags
- Financial Reporting
Patents · Patent grant
Viatris was granted a patent for meloxicam-based pain management.
In August 2026 Viatris patented a meloxicam treatment approach for managing acute, post-operative, and post-procedure pain in clinical care.
- Patent title
- Methods of using meloxicam for pain treatment and management
- Grant date
- Aug 4, 2026
- Inventors
- Susanne Vogt, Jeffrey P. Smith, Kathleen Ocasio, Joachim Maus
Showing 10 of 48+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Viatris with the Signal API
One POST /v1/companies/enrich call with viatris.com returns Viatris signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "viatris.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Viatris other signals
What signals does Autobound track for Viatris besides news and filings?
What do employees say about working at Viatris?
Has Viatris been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .